FNDC5 and breast cancer: For example, in an investigation by Provatopoulou et al., (2015), the investigators reported lower serum levels of irisin in breast cancer patients compared to those of the healthy controls, whereas Aydin et al., (2016) reported an increased level of irisin in gastrointestinal cancers.